Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Non-Current Debt (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Non-Current Debt for 16 consecutive years, with $35.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt changed N/A to $35.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $35.9 million for FY2025, N/A changed from the prior year.
  • Non-Current Debt for Q4 2025 was $35.9 million at Harvard Bioscience, up from $34.3 million in the prior quarter.
  • The five-year high for Non-Current Debt was $46.5 million in Q3 2022, with the low at $30.7 million in Q4 2023.
  • Average Non-Current Debt over 5 years is $39.4 million, with a median of $41.0 million recorded in 2021.
  • The sharpest move saw Non-Current Debt rose 11.83% in 2022, then fell 28.62% in 2023.
  • Over 5 years, Non-Current Debt stood at $45.1 million in 2021, then fell by 4.62% to $43.0 million in 2022, then dropped by 28.62% to $30.7 million in 2023, then rose by 11.56% to $34.3 million in 2024, then increased by 4.72% to $35.9 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $35.9 million, $34.3 million, and $32.0 million for Q4 2025, Q3 2024, and Q2 2024 respectively.